BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1889431)

  • 21. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography.
    Campbell DR; Flemming BK; Mason WF; Jackson SA; Hirsch DJ; MacDonald KJ
    Can Assoc Radiol J; 1990 Jun; 41(3):133-7. PubMed ID: 2354386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative trial of sodium meglumine ioxaglate (Hexabrix) and iopamidol (Niopam) for cerebral angiography.
    Molyneux AJ; Sheldon PW; Yates DA
    Br J Radiol; 1982 Dec; 55(660):881-4. PubMed ID: 6756533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low osmolality contrast media in peripheral arteriography--clinical comparison of ioxaglate, iopamidol, iohexol and diatrizoate].
    Tajima H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Nov; 45(11):1407-20. PubMed ID: 4094879
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative studies of diatrizoate, ioxaglate and iohexol as angiocardiographic contrast media].
    Esplugas E; Torrents A; Mauri J; Jara F
    Rev Esp Cardiol; 1989 Mar; 42(3):173-6. PubMed ID: 2781110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic and electrophysiologic effects of low osmolar contrast agents during coronary angiography in the dog and the rabbit.
    Doucet D; Idée JM; Donadieu AM; Bonnemain B
    Ann Radiol (Paris); 1989; 32(1):43-8. PubMed ID: 2742326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular fibrillation during right coronary arteriography with ioxaglate, iohexol and iopamidol in dogs.
    Morris TW
    Invest Radiol; 1988 Mar; 23(3):205-8. PubMed ID: 3372179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pain in peripheral arteriography: an assessment of conventional versus ionic and non-ionic low-osmolality contrast agents.
    Murphy G; Campbell DR; Fraser DB
    Can Assoc Radiol J; 1988 Jun; 39(2):103-6. PubMed ID: 2967829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative trial of Hexabrix (320 mg iodine/ml), iohexol (300 mg iodine/ml) and iopamiron (300 mg iodine/ml) in cerebral and spinal angiography: a preliminary report.
    Doyon D; Ducot B; Halimi PH; Spira A; Noviant Y; Jacolot A; Lopez-Ibor L
    Br J Radiol; 1987 Jul; 60(715):671-5. PubMed ID: 3620826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of sodium-meglumine ioxaglate and iopromide in coronary angiography.
    Neiss AC; Barth P; Chastin I; Erdmann E
    Ann Radiol (Paris); 1989; 32(1):49-53. PubMed ID: 2662884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of iohexol and ioxaglate in selective coronary angiography.
    Haagen FD; Lok D; Pasteuning H
    Can J Cardiol; 1987 Nov; 3 Suppl A():16A-20A. PubMed ID: 3435850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the PFA-100 (platelet function analyzer).
    D'Anglemont De Tassigny A; IDéE JM; Corot AC
    Invest Radiol; 2001 May; 36(5):276-82. PubMed ID: 11323515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotoxicity of iohexol, iopamidol and ioxaglate.
    Tverdal A; Haider T
    Can Assoc Radiol J; 1991 Jun; 42(3):226-7. PubMed ID: 2054686
    [No Abstract]   [Full Text] [Related]  

  • 33. Electrolyte disturbances caused by intravenous contrast media.
    Hayakawa K; Maeda M; Mitsumori M; Torizuka T; Okuno Y; Tanaka F; Matsui A; Misaki T
    Radiat Med; 1992; 10(5):171-5. PubMed ID: 1438924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of thrombosis during coronary angioplasty with low osmolality contrast media.
    Esplugas E; Cequier A; Jara F; Mauri J; Soler T; Sala J; Sabate X
    Am J Cardiol; 1991 Oct; 68(10):1020-4. PubMed ID: 1927914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of iopamidol, ioxaglate, and diatrizoate during coronary arteriography in dogs.
    Thomson KR; Evill CA; Fritzsche J; Benness GT
    Invest Radiol; 1980; 15(3):234-41. PubMed ID: 7399847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo comparative antithrombotic effects of ioxaglate and iohexol and interaction with the platelet antiaggregant clopidogrel.
    Labarthe B; Idee JM; Burnett R; Corot C
    Invest Radiol; 2003 Jan; 38(1):34-43. PubMed ID: 12496519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Miscellaneous adverse effects of low-versus high-osmolality contrast media: a study revised.
    Brismar J; Jacobsson BF; Jorulf H
    Radiology; 1991 Apr; 179(1):19-22. PubMed ID: 1826061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-osmolality contrast media-induced ventricular fibrillation.
    Hayakawa K; Yamashita K
    Invest Radiol; 1989 Apr; 24(4):298-301. PubMed ID: 2745010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulant effects of nonionic versus ionic contrast media in angiography syringes.
    Grabowski EF; Kaplan KL; Halpern EF
    Invest Radiol; 1991 May; 26(5):417-21. PubMed ID: 2055738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.